Epigenetic histone modification regulates developmental lead exposure induced hyperactivity in rats

Toxicol Lett. 2014 Feb 10;225(1):78-85. doi: 10.1016/j.toxlet.2013.11.025. Epub 2013 Dec 1.

Abstract

Lead (Pb) exposure was commonly considered as a high environmental risk factor for the development of attention-deficit/hyperactivity disorder (ADHD). However, the molecular basis of this pathological process still remains elusive. In light of the role of epigenetics in modulating the neurological disease and the causative environment, the alterations of histone modifications in the hippocampus of rats exposed by various doses of lead, along with concomitant behavioral deficits, were investigated in this study. According to the free and forced open field test, there showed that in a dosage-dependent manner, lead exposure could result in the increased locomotor activity of rats, that is, hyperactivity: a subtype of ADHD. Western blotting assays revealed that the levels of histone acetylation increased significantly in the hippocampus by chronic lead exposure, while no dramatic changes were detected in terms of expression yields of ADHD-related dopaminergic proteins, indicating that histone acetylation plays essential roles in this toxicant-involved pathogenesis. In addition, the increased level of histone acetylation might be attributed to the enzymatic activity of p300, a typical histone acetyltransferase, as the transcriptional level of p300 was significantly increased upon higher-dose Pb exposure. In summary, this study first discovered the epigenetic mechanism bridging the environmental influence (Pb) and the disease itself (ADHD) in the histone modification level, paving the way for the comprehensive understanding of ADHD's etiology and in further steps, establishing the therapy strategy of this widespread neurological disorder.

Keywords: Epigenetic; Histone acetylation; Hyperactivity; Lead (Pb).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylation
  • Age Factors
  • Animals
  • Attention Deficit Disorder with Hyperactivity / chemically induced*
  • Attention Deficit Disorder with Hyperactivity / genetics
  • Attention Deficit Disorder with Hyperactivity / metabolism
  • Attention Deficit Disorder with Hyperactivity / physiopathology
  • Attention Deficit Disorder with Hyperactivity / psychology
  • Behavior, Animal / drug effects*
  • Dopamine Plasma Membrane Transport Proteins / metabolism
  • Dose-Response Relationship, Drug
  • Epigenesis, Genetic / drug effects*
  • Female
  • Gene-Environment Interaction
  • Hippocampus / drug effects*
  • Hippocampus / metabolism
  • Hippocampus / physiopathology
  • Histones / metabolism*
  • Hyperkinesis / chemically induced*
  • Hyperkinesis / genetics
  • Hyperkinesis / metabolism
  • Hyperkinesis / physiopathology
  • Hyperkinesis / psychology
  • Lead Poisoning, Nervous System, Childhood / etiology*
  • Lead Poisoning, Nervous System, Childhood / genetics
  • Lead Poisoning, Nervous System, Childhood / metabolism
  • Lead Poisoning, Nervous System, Childhood / physiopathology
  • Lead Poisoning, Nervous System, Childhood / psychology
  • Male
  • Maternal Exposure
  • Motor Activity / drug effects*
  • Organometallic Compounds / toxicity*
  • Pregnancy
  • Prenatal Exposure Delayed Effects*
  • Protein Processing, Post-Translational / drug effects
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Dopamine D4 / drug effects
  • Receptors, Dopamine D4 / metabolism
  • p300-CBP Transcription Factors / genetics
  • p300-CBP Transcription Factors / metabolism

Substances

  • Dopamine Plasma Membrane Transport Proteins
  • Drd4 protein, rat
  • Histones
  • Organometallic Compounds
  • RNA, Messenger
  • Slc6a3 protein, rat
  • Receptors, Dopamine D4
  • p300-CBP Transcription Factors
  • p300-CBP-associated factor
  • lead acetate